Bibliography
- KAIK G: Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease. Wien. Klin. Wochenschr. (1975) 87(19):653-656.
- CHRISCHILLES E, GILDEN D, KUBISIAK J et al.: Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am. J. Manag. Care. (2002) 8(10):902-911.
- FRIEDMAN M, SERBY CW, MENJOGE SS et al.: Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest (1999) 115(3):635-641.
- DAVIS L: News roundup. Biopartnering Today Spring (2005) 4
- GlaxoSmithKline GlaxoSmithKline and Theravance to form strategic alliance (2004) Press release.
Patents
- BOEHRINGER INGELHEIM: WO03087097 (2003).
- THERAVANCE INC.: WO2004074812 (2004).
- THERAVANCE INC.: WO2004074246 (2004).
Website
- http://clinicaltrials.gov/show/NCT00239421 A 6-week study comparing the efficacy and safety of tiotropium plus formoterol with salmeterol plus fluticasone in COPD.